瘢痕子宫人工流产术前用米非司酮及米索前列醇效果观察
资料与方法,结果,讨论
【摘要】目的:探讨瘢痕子宫患者在实施人工流产术前服用米非司酮及米索前列醇所取得的实际疗效。方法:选择2021年5月—2022年10月期间我院接诊的66例瘢痕子宫产妇作为观察对象,妊娠6~10周,且均实施人工流产手术,采取随机抽样的方式将其分为对照组与研究组,各33例。对照组入院查体后直接进行人工流产,研究组在实施人工流产术之前需要使用米非司酮及米索前列醇,并记录两组患者的实际治疗情况。结果:与对照组相比,研究组患者宫颈软化、宫口扩张程度改善效果更优(P<0.05);研究组患者手术时间短于对照组,术中出血量与术后并发症发生率均低于对照组,护理满意度高于对照组,各项数据差异显著,P<0.05。结论:瘢痕子宫患者在进行人工流产术前,可通过使用米非司酮及米索前列醇的方式配合手术治疗,推进治疗,具备显著疗效,值得推广应用。【关键词】瘢痕子宫;人工流产术;米非司酮;米索前列醇
Observation on the effect of mifepristone and misoprostol before scar uterine induced abortion
HUANG Cilian
Meitan County Maternal and Child Health Care Hospital, Zunyi, Guizhou 564100, China
【Abstract】Objective:To explore the actual therapeutic effects of taking mifepristone and misoprostol before implementing artificial abortion in patients with scar uterus.Methods:A total of 66 pregnant women with scarred uterus who were admitted to our hospital from May 2021 to October 2022 were selected as the observation subjects.They were pregnant for from 6 to 10 weeks and underwent artificial abortion surgery.They were randomly divided into the control group and the study group ......
您现在查看是摘要页,全文长 9479 字符。